Adicet Bio (ACET) Operating Expenses (2017 - 2026)
Adicet Bio (ACET) posted quarterly Operating Expenses of $21.6 million for Q1 2026, down 27.82% year-over-year from $29.9 million in Q1 2025, and down 32.35% quarter-over-quarter from $31.9 million in Q4 2025.
Adicet Bio (ACET) Operating Expenses (2017 - 2026) Analysis & Trends
Adicet Bio's Operating Expenses history runs 10 years deep, the most recent figure standing at $21.6 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 27.82% year-over-year to $21.6 million; the TTM figure through Mar 2026 stood at $113.8 million (down 10.13% YoY), while the FY2025 annual figure was $122.1 million, down 4.31% from the prior year.
- Operating Expenses for Q1 2026 stood at $21.6 million, down from $31.9 million in the prior quarter.
- The five-year high for Operating Expenses was $52.3 million in Q3 2023, with the low at $20.3 million in Q1 2022.
- The 5-year median for Operating Expenses is $31.6 million (2022), against an average of $30.6 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 127.37% in 2023, then plunged 36.56% in 2024.
- Adicet Bio's Operating Expenses stood at $31.6 million in 2022, then rose by 0.0% to $31.6 million in 2023, then retreated by 2.61% to $30.7 million in 2024, then advanced by 3.72% to $31.9 million in 2025, then sank by 32.35% to $21.6 million in 2026.
- Business Quant data shows ACET's Operating Expenses at $21.6 million in Q1 2026, $31.9 million in Q4 2025, and $28.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | 22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.30 Mn |
| Mar 31, 2026 | 21.57 Mn |
| Dec 31, 2025 | 31.89 Mn |
| Sep 30, 2025 | 27.95 Mn |
| Jun 30, 2025 | 32.39 Mn |
| Mar 31, 2025 | 29.89 Mn |
| Dec 31, 2024 | 30.74 Mn |
| Sep 30, 2024 | 33.15 Mn |
| Jun 30, 2024 | 32.85 Mn |
| Mar 31, 2024 | 30.87 Mn |
| Dec 31, 2023 | 31.57 Mn |
| Sep 30, 2023 | 52.26 Mn |
| Jun 30, 2023 | 34.89 Mn |
| Mar 31, 2023 | 33.32 Mn |
| Dec 31, 2022 | 31.57 Mn |
| Sep 30, 2022 | 22.99 Mn |
| Jun 30, 2022 | 22.71 Mn |
| Mar 31, 2022 | 20.28 Mn |
| Dec 31, 2021 | 21.01 Mn |
| Sep 30, 2021 | 17.14 Mn |